KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sarepta Therapeutics (SRPT) Profit After Tax (2016 - 2025)

Historic Profit After Tax for Sarepta Therapeutics (SRPT) over the last 14 years, with Q2 2025 value amounting to $196.9 million.

  • Sarepta Therapeutics' Profit After Tax rose 294786.38% to $196.9 million in Q2 2025 from the same period last year, while for Jun 2025 it was $396.0 million, marking a year-over-year increase of 73728.78%. This contributed to the annual value of $235.2 million for FY2024, which is 14388.98% up from last year.
  • Per Sarepta Therapeutics' latest filing, its Profit After Tax stood at $196.9 million for Q2 2025, which was up 294786.38% from $159.0 million recorded in Q4 2024.
  • In the past 5 years, Sarepta Therapeutics' Profit After Tax ranged from a high of $196.9 million in Q2 2025 and a low of -$516.8 million during Q1 2023
  • In the last 5 years, Sarepta Therapeutics' Profit After Tax had a median value of -$48.1 million in 2021 and averaged -$72.1 million.
  • As far as peak fluctuations go, Sarepta Therapeutics' Profit After Tax tumbled by 85615.14% in 2021, and later skyrocketed by 294786.38% in 2025.
  • Over the past 5 years, Sarepta Therapeutics' Profit After Tax (Quarter) stood at -$122.0 million in 2021, then grew by 10.44% to -$109.2 million in 2022, then soared by 141.79% to $45.7 million in 2023, then skyrocketed by 248.37% to $159.0 million in 2024, then increased by 23.79% to $196.9 million in 2025.
  • Its Profit After Tax was $196.9 million in Q2 2025, compared to $159.0 million in Q4 2024 and $33.6 million in Q3 2024.